WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009066291) MICRORNAS EXPRESSION SIGNATURE FOR DETERMINATION OF TUMORS ORIGIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/066291    International Application No.:    PCT/IL2008/001525
Publication Date: 28.05.2009 International Filing Date: 20.11.2008
IPC:
C12Q 1/68 (2006.01)
Applicants: ROSETTA GENOMICS LTD. [IL/IL]; 10 Plaut Street, 76706 Rehovot (IL) (For All Designated States Except US).
ROSENFELD, Nitzan [IL/IL]; (IL) (For US Only).
ROSENWALD, Shai [IL/IL]; (IL) (For US Only).
BARSHACK, Iris [IL/IL]; (IL) (For US Only).
NASS, Dvora [IL/IL]; (IL) (For US Only).
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. [IL/IL]; The chaim sheba medical center, Tel Hashomer, 52621 Ramat Gan (IL) (For All Designated States Except US)
Inventors: ROSENFELD, Nitzan; (IL).
ROSENWALD, Shai; (IL).
BARSHACK, Iris; (IL).
NASS, Dvora; (IL)
Agent: SHOSHANI KUPITZ, Tzipora; Rosetta genomics Ltd., 10 Plaut Street, 76706 Rehovot (IL)
Priority Data:
60/989,458 21.11.2007 US
61/043,407 09.04.2008 US
61/073,774 19.06.2008 US
Title (EN) MICRORNAS EXPRESSION SIGNATURE FOR DETERMINATION OF TUMORS ORIGIN
(FR) SIGNATURE D'EXPRESSION DE MICRO-ARN POUR LA DÉTERMINATION DE L'ORIGINE DE TUMEURS
Abstract: front page image
(EN)The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
(FR)La présente invention porte sur un procédé de classification de l'origine spécifique de cancers et de tumeurs par l'analyse des motifs d'expression de micro-ARN spécifiques et de molécules d'acide nucléique se rapportant à ceux-ci. La classification selon un cadre d'expression des micro-ARN permet l'optimisation du traitement et la détermination d'une thérapie spécifique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)